Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.

Noh, Sangkyu; Nessim, Carolyn; Keung, Emily Z; Roland, Christina L; Strauss, Dirk; Sivarajah, Gausihi; Fiore, Marco; Biasoni, Davide; Cioffi, Stefano Piero Bernardo; Mehtsun, Winta; Cananzi, Ferdinando Carlo Maria; Sicoli, Federico; Quagliuolo, Vittorio; Chen, Jun; Luo, Chenghua; Gladdy, Rebecca A; Swallow, Carol; Johnston, Wendy; Ford, Samuel J; Evenden, Caroline; ... (2023). Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Annals of surgery, 278(2), pp. 267-273. Lippincott Williams & Wilkins 10.1097/SLA.0000000000005625

Text Retrospective_Analysis_of.175.pdf - Accepted Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy

OBJECTIVE

The Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) conducted a retrospective study on the disease course and clinical management of ganglioneuromas.

BACKGROUND

Ganglioneuromas are rare tumors derived from neural crest cells. Data on these tumors remain limited to case reports and single-institution case series.

METHODS

Patients of all ages with pathologically confirmed primary retroperitoneal, intra-abdominal, and pelvic ganglioneuromas between January 1, 2000 and January 1, 2020 were included. We examined demographic, clinicopathologic, radiologic characteristics as well as clinical management.

RESULTS

Overall, 328 patients from 29 institutions were included. The median age at diagnosis was 37 years with 59.1% of patients being female. Symptomatic presentation comprised 40.9% of cases, and tumors were often located in the extra-adrenal retroperitoneum (67.1%). At baseline, the median maximum tumor diameter was 7.2 cm. One hundred sixteen (35.4%) patients underwent active surveillance while 212 (64.6%) patients underwent resection with 74.5% of operative cases achieving an R0/R1 resection. Serial tumor evaluations showed that malignant transformation to neuroblastoma was rare (0.9%, N=3). Tumors undergoing surveillance had a median follow-up of 1.9 years, with 92.2% of ganglioneuromas stable in size. With a median follow-up of 3.0 years for resected tumors, 84.4% of patients were disease-free following resections while recurrences were observed in 4 (1.9%) patients.

CONCLUSION

Most ganglioneuromas have indolent disease courses and rarely transform to neuroblastoma. Thus, active surveillance may be appropriate for benign and asymptomatic tumors particularly when the risks of surgery outweigh the benefits. For symptomatic or growing tumors, resection may be curative.

Interest & Impact

Downloads

0 since deposited on 25 Jul 2022
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item